Non-protein amino acids and neurodegeneration: The enemy within

Experimental Neurology

Volumn 253, Issue , 2014, Pages 192-196

  Rodgers, Kenneth J ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Alzheimer's disease; BMAA; Motor neurone disease; Multiple sclerosis; Non protein amino acid; Parkinson's disease; Protein misfolding

Indexed keywords

AMINO ACID DERIVATIVE; MESSENGER RNA; NON PROTEIN AMINO ACID DERIVATIVE; UNCLASSIFIED DRUG; VEGETABLE PROTEIN;

AMINO ACID SYNTHESIS; DISEASE COURSE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FOOD CHAIN; FRUIT; GENETIC ASSOCIATION; HEALTH HAZARD; HUMAN; LEGUME; MICROORGANISM; NERVE DEGENERATION; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; NUT; ORGANISMAL INTERACTION; PATHOPHYSIOLOGY; PHYTOCHEMISTRY; PLANT PATHOGEN INTERACTION; PLANT SEED; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTAKE; REVIEW; RISK FACTOR; RNA TRANSLATION; SYMPTOM;

ALZHEIMER'S DISEASE; BMAA; MOTOR NEURONE DISEASE; MULTIPLE SCLEROSIS; NON-PROTEIN AMINO ACID; PARKINSON'S DISEASE; PROTEIN MISFOLDING;

AMINO ACIDS; ANIMALS; HUMANS; NEURODEGENERATIVE DISEASES; PROTEINS; PROTEOMICS;

EID: 84892883951     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.12.010     Document Type: Review

References (73)

1. Bell E.A. Nonprotein amino acids of plants: significance in medicine, nutrition, and agriculture. J. Agric. Food Chem. 2003, 51(10):2854-2865.
2. Bertin C., Weston L.A., Huang T., Jander G., Owens T., Meinwald J., Schroeder F.C. Grass roots chemistry: meta-tyrosine, an herbicidal nonprotein amino acid. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:16964-16969.
3. Bradley W.G., Mash D.C. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases. Amyotroph. Lateral Scler. 2009, 10(Suppl. 2):7-20.
4. Brand L.E., Pablo J., Compton A., Hammerschlag N., Mash D.C. Cyanobacterial blooms and the occurrence of the neurotoxin beta-N-methylamino-L-alanine (BMAA) in South Florida aquatic food webs. Harmful Algae 2010, 9:620-635.
5. Caller T.A., Doolin J.W., Haney J.F., Murby A.J., West K.G., Farrar H.E., Ball A., Harris B.T., Stommel E.W. A cluster of amyotrophic lateral sclerosis in New Hampshire: a possible role for toxic cyanobacteria blooms. Amyotroph. Lateral Scler. 2009, 10(Suppl. 2):101-108.
6. Chan S.W., Dunlop R.A., Rowe A., Double K.L., Rodgers K.J. L-DOPA is incorporated into brain proteins of patients treated for Parkinson's disease, inducing toxicity in human neuroblastoma cells in vitro. Exp. Neurol. 2012, 238:9.
7. Chio A., Logroscino G., Traynor B.J., Collins J., Simeone J.C., Goldstein L.A., White L.A. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 2013, 41:118-130.
8. Clement M.V., Long L.H., Ramalingam J., Halliwell B. The cytotoxicity of dopamine may be an artefact of cell culture. J. Neurochem. 2002, 81:414-421.
9. Cohen S.A. Analytical techniques for the detection of alpha-amino-beta-methylaminopropionic acid. Analyst 2012, 137:1991-2005.
10. Coppede F., Mancuso M., Siciliano G., Migliore L., Murri L. Genes and the environment in neurodegeneration. Biosci. Rep. 2006, 26:341-367.
11. Cox T.A., McDarby J.V., Lavine L., Steele J.C., Calne D.B. A retinopathy on Guam with high prevalence in Lytico-Bodig. Ophthalmology 1989, 96:1731-1735.
12. Cox P.A., Banack S.A., Murch S.J. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13380-13383.
13. Cox P.A., Richer R., Metcalf J.S., Banack S.A., Codd G.A., Bradley W.G. Cyanobacteria and BMAA exposure from desert dust: a possible link to sporadic ALS among Gulf War veterans. Amyotroph. Lateral Scler. 2009, 10(Suppl. 2):109-117.
14. de Munck E., Munoz-Saez E., Miguel B.G., Solas M.T., Ojeda I., Martinez A., Gil C., Arahuetes R.M. beta-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): the first step towards an experimental model for sporadic ALS. Environ. Toxicol. Pharmacol. 2013, 36:243-255.
15. Drummond D.A., Wilke C.O. The evolutionary consequences of erroneous protein synthesis. Nat. Rev. Genet. 2009, 10:715-724.
16. Dunlop R.A., Dean R.T., Rodgers K.J. The impact of specific oxidized amino acids on protein turnover in J774 cells. Biochem. J. 2008, 410:131-140.
17. Dunlop R.A., Cox P.A., Banack S.A., Rodgers K.J. The non-protein amino acid BMAA is misincorporated into human proteins in place of l-serine causing protein misfolding and aggregation. PLoS One 2013, 8:e75376.
18. Fowden L., Lewis D., Tristram H. Toxic amino acids: their action as antimetabolites. Adv. Enzymol. Relat. Areas Mol. Biol. 1967, 29:89-163.
19. Garruto R.M., Gajdusek C., Chen K.M. Amyotrophic lateral sclerosis among Chamorro migrants from Guam. Ann. Neurol. 1980, 8:612-619.
20. Getahun H., Mekonnen A., TekleHaimanot R., Lambein F. Epidemic of neurolathyrism in Ethiopia. Lancet 1999, 354:306-307.
21. Goto J.J., Koenig J.H., Ikeda K. The physiological effect of ingested beta-N-methylamino-L-alanine on a glutamatergic synapse in an in vivo preparation. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2012, 156:171-177.
22. Hanlon S.D., Steele J.C. An unusual retinal pigment epitheliopathy endemic to the island of Guam. Optom. Vis. Sci. 1993, 70:854-859.
23. Hendrickson T.L., de Crecy-Lagard V., Schimmel P. Incorporation of nonnatural amino acids into proteins. Annu. Rev. Biochem. 2004, 73:147-176.
24. Igloi G.L., Schiefermayr E. Amino acid discrimination by arginyl-tRNA synthetases as revealed by an examination of natural specificity variants. FEBS J. 2009, 276:1307-1318.
25. Jonasson S., Eriksson J., Berntzon L., Spacil Z., Ilag L.L., Ronnevi L.O., Rasmussen U., Bergman B. Transfer of a cyanobacterial neurotoxin within a temperate aquatic ecosystem suggests pathways for human exposure. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:9252-9257.
26. Karamyan V.T., Speth R.C. Animal models of BMAA neurotoxicity: a critical review. Life Sci. 2008, 82:233-246.
27. Karlsson O., Berg A.L., Lindstrom A.K., Hanrieder J., Arnerup G., Roman E., Bergquist J., Lindquist N.G., Brittebo E.B., Andersson M. Neonatal exposure to the cyanobacterial toxin BMAA induces changes in protein expression and neurodegeneration in adult hippocampus. Toxicol. Sci. 2012, 130:391-404.
28. Khabazian I., Bains J.S., Williams D.E., Cheung J., Wilson J.M., Pasqualotto B.A., Pelech S.L., Andersen R.J., Wang Y.T., Liu L., Nagai A., Kim S.U., Craig U.K., Shaw C.A. Isolation of various forms of sterol beta-D-glucoside from the seed of Cycas circinalis: neurotoxicity and implications for ALS-parkinsonism dementia complex. J. Neurochem. 2002, 82:516-528.
29. King A., Al-Sarraj S., Troakes C., Smith B.N., Maekawa S., Iovino M., Spillantini M.G., Shaw C.E. Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant. Acta Neuropathol. 2012, 125(2):303-310. 10.1007/s00401-012-1050-0.
30. Kurland L.T. Amyotrophic lateral sclerosis and Parkinson's disease complex on Guam linked to an environmental neurotoxin. Trends Neurosci. 1988, 11:51-54.
31. Lee J.W., Beebe K., Nangle L.A., Jang J., Longo-Guess C.M., Cook S.A., Davisson M.T., Sundberg J.P., Schimmel P., Ackerman S.L. Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature 2006, 443:50-55.
32. Malinow M.R., Bardana E.J., Pirofsky B., Craig S., McLaughlin P. Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: role of a nonprotein amino acid. Science 1982, 216:415-417.
33. Matos S.E., Conde M.T., Favero F.M., Taniguchi M., Quadros A.A., Fontes S.V., Oliveira A.S. Mortality rates due to amyotrophic lateral sclerosis in Sao Paulo City from 2002 to 2006. Arq. Neuropsiquiatr. 2012, 69:861-866.
34. Messersmith P.B. Materials science. Holding on by a hard-shell thread. Science 2010, 328(5975):180-181. 10.1126/science.1187598.
35. Miserez A., Schneberk T., Sun C., Zok F.W., Waite J.H. The transition from stiff to compliant materials in squid beaks. Science 2008, 319:1816-1819.
36. Morozova N., Weisskopf M.G., McCullough M.L., Munger K.L., Calle E.E., Thun M.J., Ascherio A. Diet and amyotrophic lateral sclerosis. Epidemiology 2008, 19:324-337.
37. Nunn P.B., Bell E.A., Watson A.A., Nash R.J. Toxicity of non-protein amino acids to humans and domestic animals. Nat. Prod. Commun. 2010, 5:485-504.
38. Ozawa K., Headlam M.J., Mouradov D., Watt S.J., Beck J.L., Rodgers K.J., Dean R.T., Huber T., Otting G., Dixon N.E. Translational incorporation of L-3,4-dihydroxyphenylalanine into proteins. FEBS J. 2005, 272:3162-3171.
39. Pablo J., Banack S.A., Cox P.A., Johnson T.E., Papapetropoulos S., Bradley W.G., Buck A., Mash D.C. Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease. Acta Neurol. Scand. 2009, 120:216-225.
40. Peterson P.J., Fowden L. Purification, properties and comparative specificities of the enzyme prolyl-transfer ribonucleic acid synthetase from Phaseolus aureus and Polygonatum multiflorum. Biochem. J. 1965, 97:112-124.
41. Plato C.C., Garruto R.M., Galasko D., Craig U.K., Plato M., Gamst A., Torres J.M., Wiederholt W. Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60years. Am. J. Epidemiol. 2003, 157:149-157.
42. Polsky F.I., Nunn P.B., Bell E.A. Distribution and toxicity of alpha-amino-beta-methylaminopropionic acid. Fed. Proc. 1972, 31:1473-1475.
43. Purdie E.L., Metcalf J.S., Kashmiri S., Codd G.A. Toxicity of the cyanobacterial neurotoxin beta-N-methylamino-L-alanine to three aquatic animal species. Amyotroph. Lateral Scler. 2009, 10(Suppl. 2):67-70.
44. Purdie E.L., Samsudin S., Eddy F.B., Codd G.A. Effects of the cyanobacterial neurotoxin beta-N-methylamino-L-alanine on the early-life stage development of zebrafish (Danio rerio). Aquat. Toxicol. 2009, 95:279-284.
45. Rao S.L., Adiga P.R., Sarma P.S. The isolation and characterization of beta-N-oxalyl-L-alpha, beta-diaminopropionic acid: a neurotoxin from the seeds of Lathyrus Sativus. Biochemistry 1964, 3:432-436.
46. Rocchi A., Pellegrini S., Siciliano G., Murri L. Causative and susceptibility genes for Alzheimer's disease: a review. Brain Res. Bull. 2003, 61:1-24.
47. Rodgers K.J., Shiozawa N. Misincorporation of amino acid analogues into proteins by biosynthesis. Int. J. Biochem. Cell Biol. 2008, 40:1452-1466.
48. Rodgers K.J., Wang H., Fu S., Dean R.T. Biosynthetic incorporation of oxidized amino acids into proteins and their cellular proteolysis. Free Radic. Biol. Med. 2002, 32:766-775.
49. Rodgers K.J., Hume P.M., Dunlop R.A., Dean R.T. Biosynthesis and turnover of DOPA-containing proteins by human cells. Free Radic. Biol. Med. 2004, 37:1756-1764.
50. Rodgers K.J., Hume P.M., Morris J.G., Dean R.T. Evidence for L-dopa incorporation into cell proteins in patients treated with levodopa. J. Neurochem. 2006, 98:1061-1067.
51. Rosenthal G.A., Dahlman D.L., Janzen D.H. A novel means for dealing with L-canavanine, a toxic metabolite. Science 1976, 192:256-258.
52. Rubenstein E. Biologic effects of and clinical disorders caused by nonprotein amino acids. Medicine (Baltimore) 2000, 79:80-89.
53. Rubenstein E. Misincorporation of the proline analog azetidine-2-carboxylic acid in the pathogenesis of multiple sclerosis: a hypothesis. J. Neuropathol. Exp. Neurol. 2008, 67:1035-1040.
54. Rubenstein E., Zhou H., Krasinska K.M., Chien A., Becker C.H. Azetidine-2-carboxylic acid in garden beets (Beta vulgaris). Phytochemistry 2006, 67:898-903.
55. Seawright A.A., Brown A.W., Nolan C.C., Cavanagh J.B. Selective degeneration of cerebellar cortical neurons caused by cycad neurotoxin, L-beta-methylaminoalanine (L-BMAA), in rats. Neuropathol. Appl. Neurobiol. 1990, 16:153-169.
56. Shaw C.A., Wilson J.M. Analysis of neurological disease in four dimensions: insight from ALS-PDC epidemiology and animal models. Neurosci. Biobehav. Rev. 2003, 27:493-505.
57. Silver R.M., Ludwicka A., Hampton M., Ohba T., Bingel S.A., Smith T., Harley R.A., Maize J., Heyes M.P. A murine model of the eosinophilia-myalgia syndrome induced by 1,1'-ethylidenebis (L-tryptophan). J. Clin. Invest. 1994, 93:1473-1480.
58. Snyder L.R., Cruz-Aguado R., Sadilek M., Galasko D., Shaw C.A., Montine T.J. Lack of cerebral bmaa in human cerebral cortex. Neurology 2009, 72:1360-1361.
59. Snyder L.R., Hoggard J.C., Montine T.J., Synovec R.E. Development and application of a comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry method for the analysis of L-beta-methylamino-alanine in human tissue. J. Chromatogr. A 2010, 1217:4639-4647.
60. Spencer P.S., Schaumburg H.H. Lathyrism: a neurotoxic disease. Neurobehav. Toxicol. Teratol. 1983, 5:625-629.
61. Spencer P.S., Roy D.N., Ludolph A., Hugon J., Dwivedi M.P., Schaumburg H.H. Lathyrism: evidence for role of the neuroexcitatory aminoacid BOAA. Lancet 1986, 2:1066-1067.
62. Spencer P.S., Hugon J., Ludolph A., Nunn P.B., Ross S.M., Roy D.N., Schaumburg H.H. Discovery and partial characterization of primate motor-system toxins. Ciba Found. Symp. 1987, 126:221-238.
63. Spencer P.S., Nunn P.B., Hugon J., Ludolph A.C., Ross S.M., Roy D.N., Robertson R.C. Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science 1987, 237:517-522.
64. Steele J.C., Guzman T. Observations about amyotrophic lateral sclerosis and the parkinsonism-dementia complex of Guam with regard to epidemiology and etiology. Can. J. Neurol. Sci. 1987, 14:358-362.
65. Thomas D.A., Rosenthal G.A. Toxicity and pharmacokinetics of the nonprotein amino acid L-canavanine in the rat. Toxicol. Appl. Pharmacol. 1987, 91:395-405.
66. Uversky V.N., Oldfield C.J., Dunker A.K. Intrinsically disordered proteins in human diseases: introducing the D2 concept. Annu. Rev. Biophys. 2008, 37:215-246.
67. Vega A., Bell E.A., Nunn P.B. The preparation of L- and D-alpha-amino- beta-methylaminopropionic acids and the identification of the compound isolated from Cycas circinalis as the L-isomer. Phytochemistry 1968, 7:1885-1887.
68. Vynnytska B.O., Mayevska O.M., Kurlishchuk Y.V., Bobak Y.P., Stasyk O.V. Canavanine augments proapoptotic effects of arginine deprivation in cultured human cancer cells. Anticancer Drugs 2010, 22:148-157.
69. Whiting M.G. Toxicity of cycads. Econ. Bot. 1963, 14:270-302.
70. Woldeamanuel Y.W., Hassan A., Zenebe G. Neurolathyrism: two Ethiopian case reports and review of the literature. J. Neurol. 2012, 259:1263-1268.
71. Xie X., Basile M., Mash D.C. Cerebral uptake and protein incorporation of cyanobacterial toxin beta-N-methylamino-L-alanine. Neuroreport 2013, 24:779-784.
72. Zaher H.S., Green R. Quality control by the ribosome following peptide bond formation. Nature 2009, 457:161-166.
73. Zesiewicz T.A. Parkinson disease: the controversy of levodopa toxicity in Parkinson disease. Nat. Rev. Neurol. 2011, 8:8-10.